Head-to-head · WeighScore
JRNYS vs LeanDose
The verdict
LeanDose takes it — 67.1/100 to 62.5/100.
LeanDose grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. LeanDose is a doctor-guided compounded GLP-1 telehealth service for eligible adults, with transparent all-inclusive first-month pricing: compounded semaglutide from $159 and tirzepatide from $279.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | JRNYS | LeanDose |
|---|---|---|
| WeighScore | 62.5/100 | 67.1/100 |
| Grade | C | C |
| Scorecard rank | #271 | #175 |
| Semaglutide | Not disclosed | $159/mo (first-month rate, compounded) |
| Tirzepatide | Not disclosed | $279/mo (first-month rate, compounded) |
| Coverage | Coverage not published | Coverage not published |
| Brand-name access | Yes | Compounded only |
| Oral / sublingual | Injection only | Injection only |
Graded #271 · C
Strengths
- Branded, FDA-approved GLP-1s — Wegovy, Ozempic, Zepbound, Mounjaro and Saxenda — rather than compounded copies
- The membership band is published before intake and is banded openly by level of coach support
- Medical visits, daily monitoring and 1-on-1 coaching are included in the membership at every tier
- Led by CMO Dr. Henry Legere (UC Berkeley, Columbia medicine, Harvard fellowship)
- Members with commercial insurance may pay around $25 a month for the medication after any deductible
Where it loses points
- The membership is overhead, not a medication price: it covers visits, monitoring and coaching, and the FAQ says medication pricing is confirmed only after a provider consultation
- No self-pay drug price is published anywhere, so the cost of a month cannot be worked out before signing up
- The best case depends on commercial insurance coverage; without it the medication cost is unknown
- No compounded option is disclosed — the programme is brand-focused, and brand list prices are the dearest route to a GLP-1
- The states it can prescribe in are not published
Graded #175 · C
Strengths
- Transparent all-inclusive first-month pricing (compounded semaglutide from $159, tirzepatide from $279)
- Verifiable LegitScript certification (seal ID 49840868) and an FDA-registered compounding pharmacy
- Doctor-prescribed and supervised, with personalized care plans and multi-state clinical support
- Convenient at-home delivery; compounded semaglutide and tirzepatide options
- Honest, modest social proof — 119 five-star patient reviews
Where it loses points
- Compounded medications are not FDA-approved — not brand Wegovy, Ozempic, Zepbound, or Mounjaro
- Headline rates are first-month pricing; your ongoing monthly cost may be higher
- Available in multiple states but the full list is not published on the homepage
- The compounding pharmacy is FDA-registered but not named
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.